(Q41104121)

26 September 2017

Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness (English)

1 reference

26 September 2017

1 reference

C Montrose-Rafizadeh

1

1 reference

26 September 2017

Y Wang

2

1 reference

26 September 2017

A M Janczewski

3

1 reference

26 September 2017

T E Henderson

4

1 reference

26 September 2017

J M Egan

5

1 reference

26 September 2017

1 June 1997

1 reference

Molecular and Cellular Endocrinology

26 September 2017

1 reference

26 September 2017

130

1 reference

26 September 2017

1-2

1 reference

26 September 2017

109-117

1 reference

Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

The incretin concept today

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucose-Stimulated Insulin Release by Individual Pancreatic Cells: Potentiation by Glyburide

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Ribonucleic acid isolated by cesium chloride centrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Buffering of calcium influx by sarcoplasmic reticulum during the action potential in guinea-pig ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Proton-induced transformation of calcium channel in chick dorsal root ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Interplay of nutrients and hormones in the regulation of insulin release

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

The relationship between glucose-induced K+ATP channel closure and the rise in [Ca2+]i in single mouse pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Glucagon-like peptide-1 is a physiological incretin in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2897%2900079-8

7 January 2021

10.1016/S0303-7207(97)00079-8

Identifiers

DOI

1 reference

26 September 2017

1 reference